167 related articles for article (PubMed ID: 34533289)
41. The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012.
Dal Maso L; Panato C; Franceschi S; Serraino D; Buzzoni C; Busco S; Ferretti S; Torrisi A; Falcini F; Zorzi M; Cirilli C; Mazzucco W; Magoni M; Collarile P; Pannozzo F; Caiazzo AL; Russo AG; Gili A; Caldarella A; Zanetti R; Michiara M; Mangone L; Filiberti RA; Fusco M; Gasparini F; Tagliabue G; Cesaraccio R; Tumino R; Gatti L; Tisano F; Piffer S; Sini GM; Mazzoleni G; Rosso S; Fanetti AC; Vaccarella S;
Eur J Cancer; 2018 May; 94():6-15. PubMed ID: 29502036
[TBL] [Abstract][Full Text] [Related]
42. Secondary cancer after meningioma diagnosis: an Israeli national study.
Ben Lassan M; Laitman Y; Keinan-Boker L; Silverman B; Friedman E
Cancer Causes Control; 2022 Oct; 33(10):1277-1284. PubMed ID: 35871439
[TBL] [Abstract][Full Text] [Related]
43. Incidence of second primary cancers in three Italian population-based cancer registries.
Buiatti E; Crocetti E; Acciai S; Gafà L; Falcini F; Milandri C; La Rosa M
Eur J Cancer; 1997 Oct; 33(11):1829-34. PubMed ID: 9470841
[TBL] [Abstract][Full Text] [Related]
44. Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study.
Heo J; Noh OK; Oh YT; Chun M; Kim L
Hepatol Int; 2017 Nov; 11(6):523-528. PubMed ID: 28983776
[TBL] [Abstract][Full Text] [Related]
45. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
46. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
Kim C; Bi X; Pan D; Chen Y; Carling T; Ma S; Udelsman R; Zhang Y
Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
[TBL] [Abstract][Full Text] [Related]
47. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based study.
Ye Y; Otahal P; Wills KE; Neil AL; Venn AJ
Cancer; 2018 Apr; 124(8):1808-1818. PubMed ID: 29370456
[TBL] [Abstract][Full Text] [Related]
48. Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis.
Lai YL; Chiang CJ; Chen YL; You SL; Chen YY; Chiang YC; Tai YJ; Hsu HC; Chen CA; Cheng WF
Cancer Med; 2021 Oct; 10(19):6845-6854. PubMed ID: 34523816
[TBL] [Abstract][Full Text] [Related]
49. Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors.
Bryk S; Pukkala E; Färkkilä A; Heikinheimo M; Unkila-Kallio L; Riska A
Int J Gynecol Cancer; 2018 Oct; 28(8):1529-1534. PubMed ID: 30036228
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
51. Use of a case-mix approach to study the trends in the incidence of second primary cancers.
Gass B; Marrer E; Bara S; Ligier K; Molinié F; Colonna M; Daubisse-Marliac L; Trétarre B; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bouvier V; Troussard X; Gaiddon C; Klein D; Velten M; Jégu J
Ann Epidemiol; 2018 May; 28(5):322-327. PubMed ID: 29550348
[TBL] [Abstract][Full Text] [Related]
52. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
[TBL] [Abstract][Full Text] [Related]
53. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
[TBL] [Abstract][Full Text] [Related]
54. Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England.
Russell B; White BE; Rous B; Wong K; Bouvier Ellis C; Srirajaskanthan R; Van Hemelrijck M; Ramage JK
Neuroendocrinology; 2023; 113(8):811-821. PubMed ID: 36940675
[TBL] [Abstract][Full Text] [Related]
55. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
56. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
[TBL] [Abstract][Full Text] [Related]
57. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
58. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
59. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
60. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
